Tampa hospital performs 100th transcatheter pulmonary valve replacement

St. Joseph’s Children’s Hospital in Tampa, Florida, performed its 100th non-invasive heart surgery Feb. 6 in which it gave a patient a transcatheter pulmonary valve.

The patient was Caleb Hancock, a 13-year-old boy, who was born with a Tetralogy of Fallot, a condition made up of four heart defects. He underwent open-heart surgery at the age of 2 and was preparing for another one this year when his doctors realized his pulmonary valve needed to be replaced.

But instead of undergoing another invasive heart surgery, Hancock was able to receive a transcatheter procedure.

The procedure was performed by Jeremy Ringewalk, MD, a pediatric interventional cardiologist and the medical director of the pediatric and adult congenital cardiac catheterization lab at St. Joseph’s.

"It was a great day for the whole team," Ringewald said. "The crew did an outstanding job."

The team at St. Joseph’s has implanted the most transcatheter pulmonary valves in Florida since the program was founded six years ago.

"We are amazed at how well Caleb is doing," said Caleb’s mother Cindy Hancock in a statement. “His recovering will be significantly shorter than what it would have been with open-heart surgery," Cindy said.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.